Prefilled Syringes Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027

Prefilled Syringes Market Forecast 2023-2027

The global prefilled syringe market size is forecast to increase by USD 3.51 billion, at a CAGR of 8.93% between 2022 and 2027. The demand for prefilled syringes (PFS) for insulin delivery is on the rise due to the increasing prevalence of diabetes. This market is witnessing substantial growth, driven by ongoing trends and analytical insights. Extensive market research and growth strategies contribute to comprehensive market analysis and detailed reports. Emphasizing market forecasting trends in growth remains paramount, enabling prefilled syringe manufacturers to effectively adapt and address the evolving requirements of the healthcare sector. As the demand for PFS continues to surge, manufacturers are poised to capitalize on emerging opportunities and deliver innovative solutions to meet the dynamic needs of the industry.

Market Overview

To learn more about this report, Download Report Sample

Market Segmentation

This market report provides a detailed analysis of the market by Material (glass pre-filled syringes and plastic pre-filled syringes ), Type ( disposable and reusable) and Geography (North America, Europe, Asia and Rest of World (ROW)).

Market Dynamics

Favorable regulations and guidelines are notably driving the market growth. Pre-filled syringes, equipped with needle safety devices, have gained significant attention in developed markets due to needlestick legislation aimed at protecting patients and healthcare professionals from needle stick injuries. These regulations are particularly relevant for chronic diseases such as heart diseases, diabetes, and autoimmune disorders, where frequent injections are required. In the US and Canada, pre-filled syringes are recommended for administering vaccines and biologics and biosimilars due to time savings and extended storage capabilities. Assumptions about the target disease population and the increasing prevalence of chronic conditions, including diabetes with its 463 million cases worldwide, and cancer with over 19 million cases, further fuel market growth. Needle stick injuries, which can lead to contaminated needles and blood-borne infections, pose a significant risk to patients and healthcare infrastructure, especially in emerging markets with insufficient funding and medical inflation. Cheaper alternatives like disposable syringes and oral drug delivery methods, such as inhalable insulin and nasal drug delivery, are being explored to address funding gaps. Safety pre-filled syringes, including glass pre-filled syringes and single-chamber pre-filled syringes, are gaining popularity due to their role in reducing drug waste and optimizing API use. Partner analysis and self-injection devices are also essential considerations for pharmaceutical companies in the development and marketing of pre-filled syringes for autoimmune disorders and biological therapies. 

The increasing number of approvals of biologics is an emerging trend shaping market growth. Pre-filled syringes have gained significant importance in the pharmaceutical industry, particularly for delivering biologics and biosimilars used to treat chronic diseases such as diabetes, multiple sclerosis, and rheumatoid arthritis. In 2022, 15 biologic drugs were approved by the FDA, nine of which were available in pre-filled syringes. This trend is driven by the advantages of pre-filled syringes, including material and cost savings, accuracy, and ease of administration. Chronic diseases like heart diseases, diabetes, and autoimmune disorders account for a large target population. Needlestick legislations and the increasing number of patients and healthcare professionals require safe and convenient drug delivery methods. Biologics and biosimilars, used to treat these diseases, are increasingly being adopted due to their long-term therapeutic benefits. Assumptions suggest that the prevalence of diabetes will reach 780 million cases by 2045, and cancer cases and autoimmune disease cases are also on the rise. Needle stick injuries and contaminated needles pose a risk for blood-borne infections, making safety a top priority. Healthcare infrastructure in emerging markets and insufficient healthcare funding, coupled with medical inflation and funding gaps, necessitate the need for cheaper alternatives like disposable syringes and oral drug delivery systems. Inhalable insulin, nasal drug delivery, and self-injection devices are also gaining popularity. Glass pre-filled syringes and single-chamber pre-filled syringes are commonly used for biological therapies. API use optimization and drug waste reduction are essential considerations for pharmaceutical companies developing drug candidates. Partner analysis is crucial for selecting the right self-injection devices and autoimmune disorder treatments.

Competition from alternative drug delivery systems is a significant challenge hindering market growth. The market is experiencing significant competition from alternative drug delivery systems, including microneedles, wearable and connected devices, and nano patches. These non-invasive technologies offer painless delivery, controlled drug release, and ease of use for patients and healthcare professionals. However, the invasive nature of pre-filled syringes can cause discomfort and needle stick injuries, leading to potential health risks such as blood-borne infections. Chronic diseases, such as heart disease, diabetes, and autoimmune disorders, require frequent medication administration. Pre-filled syringes have been widely used in the pharmaceutical industry for delivering biologics and biosimilars. However, assumptions about the target disease population and the availability of healthcare infrastructure in emerging markets may impact the market's growth. Needlestick legislation and safety concerns have led to the development of safety pre-filled syringes, particularly for self-injection devices. The geriatric population and the increasing use of biological therapies, such as glass pre-filled syringes and single-chamber pre-filled syringes, are driving market growth. However, insufficient healthcare funding, medical inflation, and funding gaps in emerging markets may limit the market's expansion. Cheaper alternatives, such as disposable syringes, oral drug delivery, inhalable insulin, and nasal drug delivery, may also impact the market share. Partner analysis and API use optimization are essential for drug candidates and drug waste reduction.

Market Segmentation by Material 

The Glass Pre-filled Syringe market segment will Dominate the Market

The Glass prefilled syringe segment was the largest and was valued at USD 3.60 billion in 2017. The segment is anticipated to significantly boost the market in focus because they are easier to regulate, more widely accepted by end users, and have a greater selection of medications than plastic. They are disposable needle systems containing pre-packaged pharmaceuticals or biologicals for injectables that are ready to use. The focus on diabetes care addressing conditions like type 1 diabetes has spurred advancements in treatments and insulin delivery methods. The choice of route of administration within the segment has gained prominence due to its effectiveness and ease of use, contributing to diverse product portfolios. It is considered the gold standard, as the material has been popular in the pharmaceutical industry for decades compared with plastic.

For more details on other segments, Download Sample Report 

Market Type Segment is further sub-segmented as Disposable and Reusable.

Disposable syringes are discarded immediately after use or exposure to an unsterile environment. Single-use needles are pivotal components within the medical field, specifically designed for one-time utilization. The availability for a wide range of therapies, including treatments for cancer and biosimilars, contributes to their growing benefits in the healthcare sector. Moreover, their cost-effectiveness compared to traditional vials is fostering their adoption, making them a preferred choice for drug delivery.

For Instance, by eliminating the possibility of reuse, single-use effectively decreases the chances of infections or the transmission of diseases from one individual to another. Healthcare practitioners and medical professionals widely recognize and adhere to the principle of single-use due to their sterile and disposable nature. The disposable attribute of single-use underscores their importance in maintaining patient safety and preventing the spread of infections or diseases. The disposable attribute of single-use needles underscores their importance in maintaining patient safety and preventing the spread of infections or diseases. Healthcare practitioners and medical professionals widely recognize and adhere to the principle of single-use due to their sterile and disposable nature. 

Key Regional Analysis

North America Holds a Prominent Position in the Market

North America dominates the market with a revenue share of around 36%. The market is experiencing significant growth in regions with high prevalence rates of chronic conditions, such as rheumatoid arthritis, cardiovascular disorders, and oncological disorders. According to the CDC, approximately 11.3% of the US population had diabetes in 2022. Technological advancements in self-administering devices like autoinjectors and pen injectors, as well as CDC recommendations, are driving market expansion. In the context of increasing healthcare costs, patient compliance, and convenient usage are crucial factors. Pre-filled syringes offer dose precision, reducing the risk of contamination and drug wastage.

However, they come with challenges such as annual cost burden, product recalls, and safety concerns like needlestick injuries. Pharmaceutical companies produce various types of pre-filled syringes, including flush syringes, safety needles, and multi-chamber needles, for injectable medications like insulin, biologics, biosimilars, and the mRNA COVID-19 vaccine. The market includes saline syringes, lubrication technology, and various types of syringes for emergency situations, such as anaphylactic shock. Healthcare providers and home care services play a significant role in the market. Global healthcare costs continue to rise, making cost-effective solutions like pre-filled needlesincreasingly important. Additionally, concerns about manual filling, conventional vials, and drug waste are influencing the market.
Regional Analysis, Global, 2017-2027

To understand geographic trends Download Report Sample

Key Players in the Market

The companies are pivotal in shaping market trends and analysis. Their strategies align with comprehensive market growth analysis and forecasting. Adapting to evolving market trends, these vendors contribute to both short-term forecasts and long-term market growth, ensuring they remain key players in meeting the growing demand for efficient and user-friendly healthcare solutions.

Companies like Catalent Inc. and Elcam Medical are integral players contributing to the evolution of safety features in syringe design and manufacturing processes, especially focusing on materials like glass to ensure product integrity. Furthermost market players like Toppac Hungary's NewCo and Stevanato Group are pioneering advancements in the healthcare industry, marking significant milestones.

The market growth and trends report also includes detailed analyses of the competitive landscape and collaboration of the market and information about 15 market companies, including:

Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, SERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc.

Segment Overview

The market growth and forecasting report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017-2021.

• Material Outlook 
  • Glass pre-filled syringes
  • Plastic pre-filled syringes
• Type Outlook 
  • Disposable
  • Reusable
• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Rest of the World (ROW)
    • Brazil
    • Argentina
    • Australia

Market Analyst Overview

The market is a significant segment in the healthcare industry, utilizing Chrono Dispensers, Needles, Plastics, Silicones, and various other materials. This market caters to the demand for Disposable Syringes, which are essential for the administration of medicines and treatments. The market is characterized by the production of Assorted Sizes and Shapes, aimed at catering to various patient needs. Chronic Diseases and Diabetes Treatment have been major drivers for the market. The market also includes the use of Advanced Technologies such as Barcode and RFID systems for improved traceability and patient safety.

Further, the market is expected to grow due to the increasing prevalence of chronic diseases and the rising demand for convenient and easy-to-use medical devices. Moreover, the market is witnessing the entry of several players, including Biologics, Pharmaceuticals, and Medical Device Companies. The market is also witnessing the trend of Customized Solutions, catering to specific patient requirements. The market is a dynamic and evolving industry, with continuous advancements in technology and increasing demand for patient-centric solutions.
 

Market Scope
Report Coverage	Details
Page number	163
Base year	2022
Historic period	2017 - 2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 8.93%
Market growth 2023-2027	USD 3.51 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	7.77
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 36%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Ajinomoto Bio Pharma Services, ApiJect Systems Corp., AptarGroup Inc., Baxter International Inc., Becton Dickinson and Co., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our market analysis and report have not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

• What is the current size of the market?
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• What is the size of the market?
• What are the main growth drivers for the market?
• What are the different types of available in the market?
• What are some of the major companies operating in the market?
• What is the current market share of in different regions?
• What are the regulatory frameworks governing the production and use of prefilled?
• What are some of the challenges faced by the market?
• What is the forecasted growth rate of the global market?
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch